Reports Search Total = 27

Europe Ophthalmology Drug and Device Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Europe
85 pages Published: 12-07-2019
  • Healthcare
  • Mordor Intelligence
  • Europe
  • 85 pages
  • Published: 12-07-2019

Market Overview

 

The European ophthalmology drug and device market is expected to register a CAGR of 5.3% during the forecast period. Certain factors that are driving the growth of the market are the growing prevalence of eye disease, technological advancements in the field of ophthalmology, and rising geriatric population.

According to Eurostat, cataract surgery is one of the most common surgical operations in Europe. This procedure was conducted more than 3.5 million times in 2015. The increasing rate of cataract surgeries has had a high impact on the ophthalmic market, resulting in the high demand for cataract surgery equipment and drugs. After 2012, the numbers have been steadily increasing, because of more and more people opting for cataract surgeries. This has contributed to the rise in demand for various cataract-related devices and drugs.

Other factors, such as a large number of eye problems, availability of new and advanced devices, and patient preference for non-invasive treatment are also expected to drive the market in the future.

However, with the rise in the rate of eye surgeries being conducted in Europe, the waiting periods have also increased. Waiting time is a highly influential factor when it comes to a patient’s preference for undergoing eye surgeries. Delaying of surgery can have an impact on the patient’s satisfaction and quality of life, because of limited functionality, increased social isolation, anxiety, higher risks for development of more complications, worsening of symptoms, or poorer prognosis and outcome following surgery. Therefore, due to longer waiting periods in some European countries, patients are opting for foreign destinations for their surgery and treatment. In many areas, cataract surgery accounts for over half of all ophthalmic surgeries. Although the European ophthalmic market shows great promise due to the increasing number of eye surgeries, it still faces challenges, owing to increased waiting periods for surgery.

Additionally, the high risk associated with eye surgery, lack of skilled technicians, and stringent regulations are also restraining the market.

 

Scope of the Report

 

Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye. An ophthalmologist is a specialist in medical and surgical eye problems, who performs operations on eyes. Ophthalmologists are specially trained to provide the full spectrum of eye care, from prescribing glasses and contact lenses to complex and delicate eye surgery. The devices include glasses, lenses, diagnostics, lasers, solutions, and surgical instruments.

 

Key Market Trends

 

Cataract Surgery Devices are Expected to Hold a Significant Market Share in the Surgical Device Type

 

According to the Royal College of Ophthalmologists, the United Kingdom, around 330,000 cataract operations are performed each year in England alone. It has been estimated that 30% of people aged 65 years or older have a visually impairing cataract in one or both eyes. Some populations tend to have a much higher prevalence of cataracts. For instance, 77% of British people, aged 42 years or older, originating from the Indian Subcontinent have cataracts. There is a threefold variation in the number of people having cataract surgery across England, owing to differences in health commissioning policies.

 

Competitive Landscape

 

The European ophthalmology drug and device market, which is highly competitive, consists of a few major players. Companies, such as Abbott Medical Optics Inc., Alcon Inc., Bausch & Lomb Inc., Carl Zeiss Meditec AG, Essilor International SA, Haag-Streit Group, Johnson & Johnson, Nidek Co. Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG, among others, hold a substantial market share in the European ophthalmology drug and device market.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Growing Prevalence of Eye Disease

4.2.2 Technological Advancements in the Field of Ophthalmology

4.2.3 Rising Geriatric Population

4.3 Market Restraints

4.3.1 High Risk Associated with Eye Surgery

4.3.2 Long Waiting Time for Surgeries

4.3.3 Stringent Regulations

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 Device

5.1.1 Surgical Device

5.1.1.1 Glaucoma Surgery Devices

5.1.1.2 Cataract Surgery Devices

5.1.1.3 Refractive Surgery Devices

5.1.1.4 Vitreoretinal Surgery Devices

5.1.1.5 Othe Surgical Devices

5.1.2 Diagnostic and Monitoring Device

5.1.2.1 Fundus Cameras

5.1.2.2 Ophthalmoscopes

5.1.2.3 Retinoscopes

5.1.2.4 Keratometers

5.1.2.5 Wavefront Aberrometers

5.1.2.6 Tonometers

5.1.2.7 Ophthalmic Ultrasound Imaging Systems

5.1.2.8 Optical Coherence Tomography Scanners

5.1.2.9 Visual Field Analyzers

5.1.2.10 Slit Lamps

5.1.2.11 Other Diagnostic and Monitoring Devices

5.1.3 Vision Care

5.1.3.1 Spectacles

5.1.3.2 Contact Lens

5.2 Drug

5.2.1 Glaucoma Drugs

5.2.2 Retinal Disorder Drugs

5.2.3 Dry Eye Drugs

5.2.4 Allergic Conjunctivitis and Inflammation Drugs

5.2.5 Other Drugs

5.3 Geography

5.3.1 Europe

5.3.1.1 UK

5.3.1.2 Germany

5.3.1.3 France

5.3.1.4 Italy

5.3.1.5 Spain

5.3.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Abbott Medical Optics Inc.

6.1.2 Alcon Inc.

6.1.3 Bausch & Lomb Inc.

6.1.4 Carl Zeiss Meditec AG

6.1.5 Essilor International SA

6.1.6 Haag-Streit Group

6.1.7 Johnson & Johnson

6.1.8 Nidek Co. Ltd

6.1.9 Topcon Corporation

6.1.10 Ziemer Ophthalmic Systems AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

Device

Surgical Device

Glaucoma Surgery Devices

Cataract Surgery Devices

Refractive Surgery Devices

Vitreoretinal Surgery Devices

Other Surgical Devices

Diagnostic and Monitoring Device

Fundus Cameras

Ophthalmoscopes

Retinoscopes

Keratometers

Wavefront Aberrometers

Tonometers

Ophthalmic Ultrasound Imaging Systems

Optical Coherence Tomography Scanners

Visual Field Analyzers

Slit Lamps

Other Diagnostic and Monitoring Devices

Vision Care

Spectacles

Contact Lens

 

Drug

Glaucoma Drugs

Retinal Disorder Drugs

Dry Eye Drugs

Allergic Conjunctivitis and Inflammation Drugs

Other Drugs

 

Geography

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Europe Novel Drug Delivery System (NDDS) Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Europe
86 pages Published: 12-07-2019
  • Healthcare
  • Mordor Intelligence
  • Europe
  • 86 pages
  • Published: 12-07-2019

Market Overview

 

The major factors that are driving growth in the European novel drug delivery system market are technological advancements promoting the development of NDDS and the rising need for controlled release of drugs.

Nowadays, for the treatment of chronic disorders as well as for controlling the release of active ingredients from drug products, a unique delivery system, the controlled release drug delivery system (CRDDS) of novel drug delivery, is included in the drug delivery technique. Majority of the active pharmaceutical ingredients are distributed in the form of CRDDS. A controlled drug delivery system is, thus, a very reliable, potential form of novel drug delivery technique, in which the drug is subjected to the appropriate pharmaceutical drug dosage form and its release is predetermined, making the release controlled at particular sites of action (cells, tissues, and organs).

Transdermal patches, implants, nasal systems, microcapsules, etc., are some of the common systems that are considered under controlled release systems. The need for controlled release of drugs is propelling the increasing demand for unique and innovative systems for drug delivery, where this novel drug delivery system plays a significant role in the advancement of controlled release of drugs, thereby driving the growth of the market, over the forecast period.

 

Scope of the Report

 

As per the scope of this report, novel drug delivery system refers to the approaches, technologies, systems, and formulations for transporting a pharmaceutical compound in the body as required to safely achieve its desired therapeutic effects. It is a novel system for the delivery of drugs, different from conventional drug delivery systems. The market is segmented by route of administration, mode of NDDS, and geography.

 

Key Market Trends

 

Targeted Drug Delivery Systems Segment under Mode of NDDS is Expected to hold the Largest Market Share during the Forecast Period

 

The targeted drug delivery system segment is expected to hold the largest share in the market owing to the benefits associated with it. Targeted drug delivery is a mixture of controlled drug delivery and sustained drug delivery systems. This method of administration of drugs assures greater efficacy, owing to the higher concentration of the drug at the target area in the body.

In the targeted drug delivery system, the drug, which is released at the site of action, then gets attached to the diseased tissue. One of the prime benefits of this mode of drug delivery is controlled and protected action, as the slow, prolonged action of the drug on the diseased tissue for an adequate period of treatment time is expected to provide potential benefits. These benefits of targeted drug delivery, coupled with the increasing need for technological advancements and a rising need for higher efficacy, owing to the increasing burden of chronic diseases, are propelling the growth of the segment.

 

Competitive Landscape

 

The market comprises major market players who are primarily focused on research and development for the creation of a stable and safe formulation. The market has been experiencing technological developments on a large scale for the past couple of years. Some of the market players are Abbott Laboratories, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, and Sanofi SA.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Technological Advancements Promoting the Development of NDDS

4.2.2 Rising Need for the Controlled Release of Drugs

4.3 Market Restraints

4.3.1 Stringent Regulatory Guidelines

4.3.2 Stability Issues

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Route of Administration

5.1.1 Oral Drug Delivery Systems

5.1.2 Injectable Drug Delivery Systems

5.1.3 Pulmonary Drug Delivery Systems

5.1.4 Transdermal Drug Delivery Systems

5.1.5 Other Routes of Administration

5.2 By Mode of NDDS

5.2.1 Targeted Drug Delivery Systems

5.2.2 Controlled Drug Delivery Systems

5.2.3 Modulated Drug Delivery Systems

5.3 Geography

5.3.1 Europe

5.3.1.1 United Kingdom

5.3.1.2 Germany

5.3.1.3 France

5.3.1.4 Italy

5.3.1.5 Spain

5.3.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Abbott Laboratories

6.1.2 AstraZeneca PLC

6.1.3 Bayer AG

6.1.4 GlaxoSmithKline PLC

6.1.5 Johnson & Johnson

6.1.6 Merck & Co. Inc.

6.1.7 Novartis AG

6.1.8 Pfizer Inc.

6.1.9 F. Hoffmann-La Roche AG

6.1.10 Sanofi SA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Route of Administration

Oral Drug Delivery Systems

Injectable Drug Delivery Systems

Pulmonary Drug Delivery Systems

Transdermal Drug Delivery Systems

Other Routes of Administration

 

By Mode of NDDS

Targeted Drug Delivery Systems

Controlled Drug Delivery Systems

Modulated Drug Delivery Systems

 

Geography

Europe

United Kingdom

Germany

France

Italy

Spain

Rest of Europe

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Europe Inflight Catering Market – Growth, Trends, and Forecast (2019 – 2024)

Aerospace & Defense Published by: Mordor Intelligence Market: Europe
106 pages Published: 12-07-2019
  • Aerospace & Defense
  • Mordor Intelligence
  • Europe
  • 106 pages
  • Published: 12-07-2019

Market Overview

 

The European inflight catering market is anticipated to register a CAGR of more than 3.5% during the forecast period.

 

Due to fierce competition in the aviation sector, where the differentiation between air carriers is minimal, food quality has emerged as one of the key points of differentiation. This trend is prevalent in Europe, where the growing tourism sector drives the aviation market. Customers start to prefer airlines that offer good amenities like inflight catering in both inbound and outbound flights to the region.

The European population is health driven and prefers fresh and nutritive food over preserved food items. The preference of the Europeans is moving toward a more balanced diet, comprising of both meat and vegetarian options that are prepared by the caterers considering the healthy food habits of the passengers.

 

Scope of the Report

 

Inflight food is the food served to passengers on board by the commercial airliner. They are prepared by specialist airline catering providers and are normally served during the cruise to the passengers. The beverage segment mentioned in the report comprises coffee, tea, hot chocolate, milk, cold-drink, and alcohol. The other food types segment largely encompasses varieties of cheese with fruit, ice cream, condiments, and other add-on supplements (such as jams, sauces, salt, pepper, margarine, sugar, etc.), which are supplied in small sachets. Furthermore, in segmentation by class, the premium economy class has been covered under the aircraft seating class segment.

 

Key Market Trends

 

Meals segment dominates the Europe Inflight Catering Market

 

The food available on a flight is usually free of charge on full-service European airlines and on almost all long-distance flights. Meals are expected to be the dominant food type in the European inflight catering market during the forecast period. However, their share is not far from the bakery and confectionery segment, whose share in the European inflight catering market is particularly more than that of the other regions, as the passengers from the region prefer bread and other baked items in most of their dining. The inflight dinners for most of the European airlines include meat (most commonly chicken or beef), a salad or vegetable, a small roll, bread, cheese, and a dessert. During morning flights, cooked breakfast or a lighter, continental-style meal is provided. On certain long-haul flights (and short/medium haul flights within Europe), breakfast usually includes confectionaries like pancakes, along with eggs and other traditional breakfast foods, such as sausages, fruits, and grilled tomatoes.

 

The United Kingdom having the highest market share

 

The United Kingdom stands first in the number of passengers traveling by air in the European Union. The global passenger traffic in the United Kingdom was 151.87 million in 2017. This is 49.60% growth when compared to 101.51 million passengers handled by the airports of the United Kingdom in 2010. The presence of major airlines, like British Airways and EasyJet which are currently increasing their global connectivity with the introduction of new destinations, is expected to bring new menus on board the aircraft. British Airways is expected to introduce 13 new routes in 2019, in which 12 are from London and one is from Germany. Such new routes will encourage airlines to introduce destination specific meals.

 

Competitive Landscape

 

LSG Sky Chef and Gate Gourmet accounted for a significant share in 2018. In September 2018, British Airways signed an agreement with Do&Co catering for serving all outbound service from Heathrow. The airline currently uses Gate Gourmet for all other catering on flights departing Heathrow, but from October the carrier will begin a phased switch over to new Do&Co menus, with all outbound services in all classes expected to be covered by early 2020. This move may further reduce the share of Gate Gourmet, while simultaneously increasing the revenues of Do&Co.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.3 Market Restraints

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 Aircraft Seating Class

5.1.1 Economy

5.1.2 Business

5.1.3 First

5.1.4 Other Aircraft Seating Classes

5.2 Flight Service Type

5.2.1 FSC

5.2.2 LCC

5.2.3 Other Flight Service Types

5.3 Food Type

5.3.1 Meals

5.3.2 Bakery and Confectionery

5.3.3 Beverages

5.3.4 Other Food Types

5.4 Country

5.4.1 Russia

5.4.2 Germany

5.4.3 France

5.4.4 UK

5.4.5 Italy

5.4.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements

6.2 Vendor Market Share

6.3 Strategies Adopted by Leading Players

6.4 Company Profiles

6.4.1 Flying Food Group, LLC

6.4.2 DO & CO

6.4.3 Gate Gourmet

6.4.4 Lufthansa Service Holding AG

6.4.5 Journey Group PLC

6.4.6 Emirates Flight Catering

6.4.7 Cathay Pacific Catering Services (CLS Catering)

6.4.8 JetFinity

6.4.9 Newrest International Group S.A.S

6.4.10 dnata

6.4.11 SATS Ltd

6.4.12 IGS Ground Services

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

Aircraft Seating Class

Economy

Business

First

Other Aircraft Seating Classes

 

Flight Service Type

FSC

LCC

Other Flight Service Types

 

Food Type

Meals

Bakery and Confectionery

Beverages

Other Food Types

 

Country

Russia

Germany

France

UK

Italy

Rest of Europe

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Europe Hospital Supplies Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Europe
69 pages Published: 12-07-2019
  • Healthcare
  • Mordor Intelligence
  • Europe
  • 69 pages
  • Published: 12-07-2019

Market Overview

 

The propelling factors for the growth of the European hospital supplies market include the high demand, owing to increasing chronic diseases and rising geriatric population, and the investment in healthcare infrastructure.

 

– There is a growing concern about chronic diseases, which affect one-third of the European population aged 15 and above. This rising awareness is increasing the hospital admission rates, which in turn, is fueling the overall market growth in Europe.

– In addition, the fact that the geriatric population is more susceptible to acute and chronic diseases indicates that the increased geriatric population is also highly responsible for high hospital admission rate, thus pushing the demand of this market.

– Europe has a strong healthcare system, in terms of the infrastructure, hospital beds, hospital supplies, and equipment, etc., that has helped the overall market to account among the highest market share. Therefore, the well-established infrastructure of the hospitals helps in the growth of the European hospital supplies market.

– On the other side, the preference of home care is also rising as the home is a place of emotional and physical associations, memories, and comfort and it also keeps families together, which is particularly important during long-term illness. Therefore, the rising usage of home care consequently restrains the hospital admission rates and further impedes the growth of the studied market.

 

Scope of the Report

 

As per the scope of the report, medical supplies are found to be the specific products, which are used for patient examinations, mobility aids, and transportation purposes. Hospital supplies also mainly consist of the supplies, such as disinfectant and sterilization equipment, transportation and mobility aids equipment, patient examination devices, operating room equipment, and syringes and needles. The usage of hospital supplies is being highly driven by rising hospital admission rates and growing health awareness.

 

Key Market Trends

 

The Operating Room Equipment Segment is Expected to Creating Lucrative Growth Opportunities During the Forecast Period

 

With the growing immigration from African countries and other Mediterranean countries, the surgical procedures have significantly increased, further demanding the technological advancement in operating room equipment. Therefore, several companies are looking toward the development of state-of-the-art operating rooms, which are creating lucrative growth opportunities. Additionally, there is an increasing number of super specialty hospitals that help in the overall growth of the market.

 

Competitive Landscape

 

There are several key players found to be involved in merger and acquisition and their geographical expansion are among the latest trends that have been observed in the European hospital equipment and supplies market.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 High Demand Owing To Chronic Disease and Rising Geriatric Population

4.2.2 Investment in Healthcare Infrastructure

4.3 Market Restraints

4.3.1 Emergence of Home Care Services

4.3.2 Stringent Regulatory Bodies

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product Type

5.1.1 Patient Examination Device

5.1.2 Operating Room Equipment

5.1.3 Mobility Aids and Transportation Equipment

5.1.4 Syringes and Needles

5.1.5 Sterilization and Disinfectant Equipment

5.1.6 Other Product Types

5.2 Geography

5.2.1 Europe

5.2.1.1 Germany

5.2.1.2 UK

5.2.1.3 France

5.2.1.4 Italy

5.2.1.5 Spain

5.2.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Medtronic PLC

6.1.2 Baxter International Inc.

6.1.3 Cardinal Health Inc.

6.1.4 Becton Dickinson & Company

6.1.5 Boston Scientific Group

6.1.6 Ethicon (Johnson & Johnson)

6.1.7 3M Company

6.1.8 B. Braun Melsungen AG

6.1.9 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Product Type

Patient Examination Device

Operating Room Equipment

Mobility Aids and Transportation Equipment

Syringes and Needles

Sterilization and Disinfectant Equipment

Other Product Types

 

Geography

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Europe Hemodynamic Monitoring Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Europe
85 pages Published: 12-07-2019
  • Healthcare
  • Mordor Intelligence
  • Europe
  • 85 pages
  • Published: 12-07-2019

Market Overview

 

The European market for hemodynamic monitoring is expected to register a CAGR of around 5.0% over the forecast period, 2019-2024. Factors that are augmenting the growth of the market in the European region are increasing critically ill geriatric population, the rise in the prevalence of cardiac disorders and diabetes, and increasing demand for home-based and non-invasive monitoring systems.

In Europe, the Ageing Report is published every three years by the Ageing Working Group of the Economic Policy Committee (EPC) and the European Commission’s Directorate-General for Economic and Financial Affairs (DG ECFIN), based on a mandate by the Council. As per the latest report by EPC (2018), the cost of ageing in the region is believed to grow by 1.7% to 26.7% of the GDP, till 2070. This long-term analysis was done to understand the negative impact of ageing in the European region. As the ageing population is increasing, there is a rising demand for monitoring tools, which is accelerating the growth of the hemodynamic monitoring market.

Certain factors, such as technological advances in the healthcare industry, along with its rapid adoption, are also fuelling the market. 

 

Scope of the Report

 

Critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, which are also known as hemodynamic systems. The main function of these systems is to monitor cardiac activity. The hemodynamic systems give information about blood pressure, blood volume, and fluid balance.

This report contains a detailed analysis of the types of systems, application, and products that are available in the hemodynamic monitoring market.

 

Key Market Trends

 

Hospital-based Monitoring Systems are Expected to Grab the Largest Market Share in the Application Segment

 

In the application segment of the market, hospital-based monitoring systems are believed to have the largest market share in the coming future. 

Hospitals face multiple challenges in assessing multiple blood parameters in intensive care units, emergency rooms, and other departments. A majority of critically ill patients admitted to the ER are anemic, with over a third requiring a blood transfusion. Repeated blood draws have been observed to increase organ dysfunction and morbidity in such patients. Patients with anemia are more likely to have in-hospital complications, including heart failure, recurrent ischemia, re-infarction, cardiogenic shock, stroke, major bleeding, and hypoxia. Therefore, in hospitals, particularly in intensive care and emergency units, continuous monitoring of hemodynamics can optimize diagnosis, and minimize complications and hospitalization time.

Owing to the importance of hemodynamic monitors in hospitals and the rising need for the same, for better care provision, the segment is expected to grow.

 

Competitive Landscape

 

The market is moderately competitive, with the presence of some big players, such as Edward Lifesciences, Getinge Group, Koninklijke Philips NV, ICU Medical, and Lidco Group. Additionally, there are few smaller players in the market that are holding sufficient market share. Due to the growing healthcare industry and the continuous technological advances that are being done to provide medical care, new companies are expected to enter the market in the coming future.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.3 Market Restraints

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Type of Systems

5.1.1 Minimally-invasive Monitoring Systems

5.1.2 Invasive Monitoring Systems

5.1.3 Non-invasive Monitoring Systems

5.2 By Application

5.2.1 Laboratory-based Monitoring Systems

5.2.2 Home-based Monitoring Systems

5.2.3 Hospital-based Monitoring Systems

5.3 By Type of Product

5.3.1 Pressure Monitors

5.3.2 Catheters

5.3.3 Connecting Tubes

5.3.4 Guidewires

5.3.5 IV Fluid

5.3.6 Transducers

5.4 Geography

5.4.1 Europe

5.4.1.1 Germany

5.4.1.2 UK

5.4.1.3 France

5.4.1.4 Italy

5.4.1.5 Spain

5.4.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Cheetah Medical

6.1.2 CN Systems

6.1.3 Edwards Lifesciences

6.1.4 Evena Medical

6.1.5 Getinge AB

6.1.6 ICU Medical

6.1.7 Koninklijke Philips NV

6.1.8 Lidco Group

6.1.9 Schwarzer Cardiotek

6.1.10 Tensys Medical

6.1.11 Uscom

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Type of Systems

Minimally-invasive Monitoring Systems

Invasive Monitoring Systems

Non-invasive Monitoring Systems

 

By Application

Laboratory-based Monitoring Systems

Home-based Monitoring Systems

Hospital-based Monitoring Systems

 

By Type of Product

Pressure Monitors

Catheters

Connecting Tubes

Guidewires

IV Fluid

Transducers

 

Geography

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Europe Epigenetics Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Europe
71 pages Published: 12-07-2019
  • Healthcare
  • Mordor Intelligence
  • Europe
  • 71 pages
  • Published: 12-07-2019

Market Overview

 

The European epigenetics market is expected to register a CAGR of nearly 14.5% over the forecast period. Factors that are responsible for the growth of this market include the increasing incidence and prevalence of cancer, the increased funding for R&D in healthcare, and rising epigenetic applications in non-oncology diseases.

 

The epigenetics market is increasing in the European region. For instance, according to WHO, more than 3.7 million new cases of cancer and 1.9 million deaths occur due to cancer every year, and cancer represents the second most important cause of death and morbidity in the European region. Epigenetics is used in the study of changes in gene expression, which are useful in cancer diagnosis. This depicts the large patient pool of cancer patients, which will propel the growth of the epigenetics market. So, with the increasing cancer prevalence, the market is expected to grow. However, factors, such as the rising cost of instruments are expected to restrain the growth of the market.

 

Scope of the Report

 

Epigenetics is defined as the study of changes in gene expression, which are caused by certain base pairs in DNA, or RNA, being turned off or on again, through the chemical reactions.

 

Key Market Trends

 

Oncology is Expected to Grow Faster in the Application Segment

 

In the last few years, the market has been a golden age for cancer genetics. The cost of gene sequencing has dropped low enough for researchers to read the genomes of many thousands of patients, comparing the DNA of the diseased and healthy tissues to find the mutations associated with tumor formation and growth, which is associated with cancer. The epigenetic innovations are unobtrusively crafting a toolbox for the powerful drugs to treat cancer. And the rising prevalence of cancer in the European region is expected to drive the oncology application in the European epigenetic market.

 

Competitive Landscape

 

The European epigenetic market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. With the rising need for mobile health and the advances in ultrasonography, a few smaller players are entering the market and holding a substantial share. Some of the major players of the market are Merck & Co., Qiagen, Roche, Thermo Fisher Scientific, and Illumina Inc., among others.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Incidence and Prevalence of Cancer

4.2.2 Increasing Funding for R&D in Healthcare

4.2.3 Rising Epigenetic Applications in Non-Oncology Diseases

4.3 Market Restraints

4.3.1 Rising Cost of Instruments

4.3.2 Dearth of Skilled researchers

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product

5.1.1 By kits

5.1.1.1 Bisulfite Conversion Kits

5.1.1.2 Chip-seq Kits

5.1.1.3 RNA Sequencing Market

5.1.1.4 Whole Genome Amplification Market

5.1.1.5 5-HMC and 5-MC Analysis Kits

5.1.1.6 Other Kits

5.1.2 By Reagents

5.1.2.1 Antibodies

5.1.2.2 Buffers

5.1.2.3 Histones

5.1.2.4 Magnetic Beads

5.1.2.5 Primers

5.1.2.6 Other Reagents

5.1.3 By Enzymes

5.1.3.1 DNA – Modifying Enzymes

5.1.3.2 Protein Modifying Enzymes

5.1.3.3 RNA Modifying Enzymes

5.1.4 By Instruments

5.1.4.1 Mass Spectrometer

5.1.4.2 Sonicators

5.1.4.3 Next Generation Sequencers

5.1.4.4 Other Instruments

5.1.5 By Application

5.1.5.1 Oncology

5.1.5.2 Non-Oncology

5.1.5.2.1 Inflammatory Diseases

5.1.5.2.2 Metabolic Diseases

5.1.5.2.3 Infectious Diseases

5.1.5.2.4 Cardiovascular Diseases

5.1.5.2.5 Other Non-Oncology Applications

5.1.5.3 Developmental Biology

5.1.5.4 Other Research Areas

5.1.6 By Technology

5.1.6.1 DNA Methylation

5.1.6.2 Histone Methylation

5.1.6.3 Histone Acetylation

5.1.6.4 Large noncoding RNA

5.1.6.5 MicroRNA modification

5.1.6.6 Chromatin Structures

5.2 Geography

5.2.1 Europe

5.2.1.1 Germany

5.2.1.2 UK

5.2.1.3 France

5.2.1.4 Italy

5.2.1.5 Spain

5.2.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Diagenode Inc.

6.1.2 Epitherapeutics

6.1.3 Illumina, Inc.

6.1.4 Merck & Co.

6.1.5 Qiagen

6.1.6 F. Hoffmann-La Roche AG

6.1.7 Thermo Fisher Scientific

6.1.8 Zymo Research Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Product

By Kits

Bisulfite Conversion Kits

Chip-seq Kits

RNA Sequencing Market

Whole Genome Amplification Market

5-HMC and 5-MC Analysis Kits

Other Kits

By Reagents

Antibodies

Buffers

Histones

Magnetic Beads

Primers

Other Reagents

By Enzymes

DNA – Modifying Enzymes

Protein Modifying Enzymes

RNA Modifying Enzymes

By Instruments

Mass Spectrometer

Sonicators

Next Generation Sequencers

Other Instruments

By Application

Oncology

Non-Oncology

Inflammatory Diseases

Metabolic Diseases

Infectious Diseases

Cardiovascular Diseases

Other Non-Oncology Applications

Developmental Biology

Other Research Areas

By Technology

DNA Methylation

Histone Methylation

Histone Acetylation

Large noncoding RNA

MicroRNA modification

Chromatin Structures

 

Geography

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type